explore -WSS

explore

author：knowledge 2025-08-26 10:54:37 - browse：5796

Capitol Riot Maine — FILE - Violent rioters supporting President Donald Trump storm the Capitol in Washington, Wednesday, Jan. 6, 2021. A former Republican legislative candidate who traveled to Washington for former President Donald Trump's “Stop the Steal” rally was arrested Friday, July 21, 2023, and charged with federal crimes for his role in the U.S. Capitol riot, officials said. (AP Photo/John Minchillo, File)The Associated Press

PORTLAND, Maine -- A former Republican legislative candidate who traveled to Washington for former President Donald Trump's “Stop the Steal” rally was arrested Friday and charged with federal crimes for his role in the U.S. Capitol riot, officials said.

Matthew Brackley, 39, of Waldoboro, Maine, entered the the Capitol on Jan. 6, 2021, and asked for the location of House Speaker Nancy Pelosi’s office before shouting, “Let’s go," according to prosecutors.

He was arrested on felony charges including assaulting, resisting or impeding certain officers and civil disorder, along with several misdemeanors. He made his initial court appearance on Friday.

It was not clear if Brackley had a lawyer, and he did not immediately respond to an email request for comment.

Brackley tried unsuccessfully to unseat Democratic state Sen. Eloise Vitelli of Arrowsic last year. His campaign website described him as a Maine Maritime Academy graduate whose approach would be to have “respectful, thoughtful conversations on the issues.”

At the Capitol, prosecutors said, Brackley led a group that pushed through police officers several times before ultimately being dispersed by chemical spray and exiting.

More than 1,000 people have been charged with federal crimes related to the Jan. 6 attack.

Approximately 100 of them have been convicted by juries or judges after trials, and more than 600 have pleaded guilty.

Over 570 riot defendants have been sentenced, with more than half receiving prison terms ranging from three days to 18 years.

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： AstraZeneca to buy developer of next

WSS

Virtual Event: March of the Biosimilars

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Baby aspirin cuts fat buildup in liver disease patients, in small study

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Neuroscience’s long legacy of racism

knowledge

explore

Wikipedia

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Colonoscopy prep: Liquid

Hollywood unions extend contract negotiations for actors

Leading voice in opioid treatment defends methadone clinic system

New air purifier tech could be key to improving indoor air quality

Orchard's therapy for neuron disease in children wins FDA approval

23andMe had bad news about my health. I wish a person had delivered it

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Duchenne breakthrough therapy leaves behind pioneering families

U.K. researchers warn about biases in medical devices, algorithms

hotspot

Health AI adoption puts security, privacy startups on investors' radar

Future doctors should be trained to promote social change

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Creating egg and sperm cells from stem cells raises ethical issues

UnitedHealth increases loan offers after Change Healthcare outage

SCOTUS questions limit to govt efforts to fight misinformation

hotspot

explore

focus

leisure time